Christoph Petry
Directeur Général chez m2p-labs GmbH
Profil
Christoph Petry founded Myriad International GmbH in 2010, where he worked as Chief Executive Officer & Managing Director.
Dr. Petry also currently works at m2p-labs GmbH, as Co-Managing Director & Chief Technology Officer from 2017.
Dr. Petry also formerly worked at Prostatype Genomics AB, as Director, Bayer AG, as Head-Research & Development, Siemens AG, as Head-Molecular Research, and Bayer Diagnostics Corp., as Principal.
Dr. Petry received his graduate degree from Friedrich-Alexander University of Erlangen-Nuremberg.
Postes actifs de Christoph Petry
| Sociétés | Poste | Début |
|---|---|---|
m2p-labs GmbH
 m2p-labs GmbH BiotechnologyHealth Technology m2p-labs GmbH manufactures and supplies micro bioreactors. The firm focuses on micro reaction and automated solutions for screening and bioprocess development. Its commercialized products are the BioLector and the FlowerPlate which provide an intelligent micro fermentation platform. The firm's technology empowers the biotechnology, chemical and pharmaceutical industry to increase their number and information of microbial and cell culture experiments. The company was founded by Ingo Klammer, Carsten Müller, Mirko C. Hofmann and Frank Kensy on November 22, 2005 and is headquartered in Baesweiler, Germany. | Directeur Général | 01/10/2017 |
Anciens postes connus de Christoph Petry
| Sociétés | Poste | Fin |
|---|---|---|
| BAYER AG | Directeur Technique/Scientifique/R&D | - |
| PROSTATYPE GENOMICS AB | Directeur/Membre du Conseil | - |
Myriad International GmbH
 Myriad International GmbH Medical/Nursing ServicesHealth Services Myriad International GmbH provides diagnostics services in oncology. Its products include EndoPredict, Report Generator and ChemoPredict. The firm conducts research with clinical and scientific partners. The company was founded by Ralf Kronenwett, Christoph Petry and Kerstin Bohmann in July 2010 and is headquartered in Cologne, Germany. | Directeur Général | - |
| SIEMENS AG | Directeur Technique/Scientifique/R&D | 02/09/2011 |
| Bayer Diagnostics Corp. | Corporate Officer/Principal | - |
Formation de Christoph Petry
| Friedrich-Alexander University of Erlangen-Nuremberg | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BAYER AG | Health Technology |
| SIEMENS AG | Producer Manufacturing |
| PROSTATYPE GENOMICS AB | Health Technology |
| Entreprise privées | 3 |
|---|---|
| Bayer Diagnostics Corp. | Health Technology |
Myriad International GmbH
Myriad International GmbH Medical/Nursing ServicesHealth Services Myriad International GmbH provides diagnostics services in oncology. Its products include EndoPredict, Report Generator and ChemoPredict. The firm conducts research with clinical and scientific partners. The company was founded by Ralf Kronenwett, Christoph Petry and Kerstin Bohmann in July 2010 and is headquartered in Cologne, Germany. | Health Services |
m2p-labs GmbH
m2p-labs GmbH BiotechnologyHealth Technology m2p-labs GmbH manufactures and supplies micro bioreactors. The firm focuses on micro reaction and automated solutions for screening and bioprocess development. Its commercialized products are the BioLector and the FlowerPlate which provide an intelligent micro fermentation platform. The firm's technology empowers the biotechnology, chemical and pharmaceutical industry to increase their number and information of microbial and cell culture experiments. The company was founded by Ingo Klammer, Carsten Müller, Mirko C. Hofmann and Frank Kensy on November 22, 2005 and is headquartered in Baesweiler, Germany. | Health Technology |
